share_log

Are Investors Undervaluing Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) By 33%?

投資家は、青島ノベルビームテクノロジー株式会社(SHSE:688677)を33%低く評価していますか?

Simply Wall St ·  07/03 20:16

Key Insights

  • Using the 2 Stage Free Cash Flow to Equity, Qingdao NovelBeam TechnologyLtd fair value estimate is CN¥53.88
  • Qingdao NovelBeam TechnologyLtd is estimated to be 33% undervalued based on current share price of CN¥36.17
  • Analyst price target for 688677 is CN¥54.25 which is similar to our fair value estimate

How far off is Qingdao NovelBeam Technology Co.,Ltd. (SHSE:688677) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.

We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

The Model

We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) forecast

2025 2026 2027 2028 2029 2030 2031 2032 2033 2034
Levered FCF (CN¥, Millions) CN¥142.0m CN¥195.2m CN¥248.2m CN¥297.5m CN¥341.5m CN¥379.8m CN¥412.9m CN¥441.7m CN¥467.1m CN¥489.9m
Growth Rate Estimate Source Est @ 52.36% Est @ 37.52% Est @ 27.13% Est @ 19.86% Est @ 14.77% Est @ 11.21% Est @ 8.72% Est @ 6.97% Est @ 5.75% Est @ 4.90%
Present Value (CN¥, Millions) Discounted @ 8.2% CN¥131 CN¥167 CN¥196 CN¥217 CN¥231 CN¥237 CN¥239 CN¥236 CN¥231 CN¥224

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = CN¥2.1b

We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.9%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.2%.

Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = CN¥490m× (1 + 2.9%) ÷ (8.2%– 2.9%) = CN¥9.6b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CN¥9.6b÷ ( 1 + 8.2%)10= CN¥4.4b

The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is CN¥6.5b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of CN¥36.2, the company appears quite undervalued at a 33% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind.

dcf
SHSE:688677 Discounted Cash Flow July 4th 2024

Important Assumptions

We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Qingdao NovelBeam TechnologyLtd as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.2%, which is based on a levered beta of 0.933. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

SWOT Analysis for Qingdao NovelBeam TechnologyLtd

Strength
  • Debt is not viewed as a risk.
  • Dividends are covered by earnings and cash flows.
  • Dividend information for 688677.
Weakness
  • Earnings declined over the past year.
  • Dividend is low compared to the top 25% of dividend payers in the Medical Equipment market.
  • What are analysts forecasting for 688677?
Opportunity
  • Annual earnings are forecast to grow faster than the Chinese market.
  • Trading below our estimate of fair value by more than 20%.
Threat
  • No apparent threats visible for 688677.

Next Steps:

Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. The DCF model is not a perfect stock valuation tool. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. Why is the intrinsic value higher than the current share price? For Qingdao NovelBeam TechnologyLtd, there are three further aspects you should look at:

  1. Risks: You should be aware of the 1 warning sign for Qingdao NovelBeam TechnologyLtd we've uncovered before considering an investment in the company.
  2. Future Earnings: How does 688677's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every Chinese stock every day, so if you want to find the intrinsic value of any other stock just search here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする